Skip to content

BTP-1000L-2 02-00139Recalls & reported problems

Braemar Manufacturing, LLC · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI B146BTPL20), received between Mar 19, 2024 and Mar 19, 2024 — classified as 1 injury.

The most frequently reported specific device problem is “Biocompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Biocompatibility1

Patient problems

  • Hemorrhage/Blood Loss/Bleeding1
  • Pain1
  • Rash1
  • Skin Inflammation/ Irritation1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 19, 2024Biocompatibility; Biocompatibility

    IT WAS REPORTED THAT ON (B)(6) 2024, THE PATIENT WAS EXPERIENCING A RASH WHILE WEARLING THE LEAD WIRE ADAPATER (LWA). THE PATIENT NOTED THAT THE THE RASH HAD SPREAD TO THE NIPPLE/BREAST AREA AND BRUISING WAS PRESENT. THEY WERE EXPERIENCING BLEEDING, SCRAPPINESS, OOZING AND RAWNESS THAT IS VERY PAINFUL. THE PATIENT CONTACTED THEIR DERMATOLOGIST REGARDING THE RASH AND THEY WERE PRESCRIBED DOXYCYCLINE TO TAKE TO RELIEVE IRRITATION. THE PATIENT'S CARDIOLOGIST ADVISED THE PATIENT TO CONTINUE MONITORING. THE PATIENT REPORTED THAT THEY HAVE NUMEROUS ALLERGIES TO TRIPLE OINTMENT INGREDIENTS AND LATEX AND A MILD ADHESIVE ALLERGY. IT IS THOUGHT THE SKIN IRRITATION IS DUE TO THE ELECTRODES.

    Patient problems: Hemorrhage/Blood Loss/Bleeding; Pain; Rash; Skin Inflammation/ Irritation

    MAUDE report 18935598 ↗

Other Cable, Electrode devices

All Cable, Electrode devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page